Clinical Trial Results:
Phase II, double blind, intermittent dose, placebo controlled, randomised, two period crossover study to investigate the effect of inhaled doses of VR776 administered via Aspirair inhaler on IVELT (intravaginal ejaculatory latency time) measured by stop watch in male patients with premature ejaculation
Summary
|
|
EudraCT number |
2005-004065-42 |
Trial protocol |
GB |
Global completion date |
15 Mar 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Jul 2016
|
First version publication date |
28 Jul 2016
|
Other versions |
|
Summary report(s) |
Study VR776/008 synopsis for EudraCT (July 2016) |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.